OrthoPediatrics Corp. (NASDAQ:KIDS – Get Free Report) was the recipient of a large growth in short interest during the month of December. As of December 31st, there was short interest totalling 912,100 shares, a growth of 10.9% from the December 15th total of 822,400 shares. Based on an average daily volume of 211,000 shares, the short-interest ratio is currently 4.3 days. Currently, 5.6% of the company’s shares are short sold.
OrthoPediatrics Stock Performance
NASDAQ:KIDS opened at $27.16 on Monday. OrthoPediatrics has a 52 week low of $21.02 and a 52 week high of $35.99. The company has a fifty day simple moving average of $23.98 and a two-hundred day simple moving average of $27.33. The company has a quick ratio of 3.68, a current ratio of 7.17 and a debt-to-equity ratio of 0.19. The company has a market cap of $657.82 million, a price-to-earnings ratio of -22.08 and a beta of 1.14.
Wall Street Analysts Forecast Growth
KIDS has been the topic of a number of research reports. Needham & Company LLC restated a “buy” rating and set a $42.00 price target on shares of OrthoPediatrics in a research note on Tuesday, January 14th. Truist Financial lowered their target price on OrthoPediatrics from $28.00 to $25.00 and set a “hold” rating for the company in a report on Wednesday, December 18th.
Institutional Inflows and Outflows
Several institutional investors and hedge funds have recently added to or reduced their stakes in KIDS. Quarry LP acquired a new stake in shares of OrthoPediatrics in the 3rd quarter valued at $25,000. International Assets Investment Management LLC increased its holdings in OrthoPediatrics by 2,610.8% in the third quarter. International Assets Investment Management LLC now owns 1,003 shares of the company’s stock valued at $27,000 after buying an additional 966 shares during the last quarter. Quest Partners LLC acquired a new stake in OrthoPediatrics in the second quarter valued at $34,000. BNP Paribas Financial Markets lifted its holdings in OrthoPediatrics by 125.1% during the 3rd quarter. BNP Paribas Financial Markets now owns 3,471 shares of the company’s stock worth $94,000 after buying an additional 1,929 shares during the last quarter. Finally, Quantbot Technologies LP increased its holdings in shares of OrthoPediatrics by 42.2% in the 3rd quarter. Quantbot Technologies LP now owns 5,773 shares of the company’s stock valued at $157,000 after acquiring an additional 1,712 shares during the last quarter. Institutional investors and hedge funds own 69.05% of the company’s stock.
About OrthoPediatrics
OrthoPediatrics Corp., a medical device company, engages in designing, developing, and marketing anatomically appropriate implants, instruments, and specialized braces for children with orthopedic conditions in the United States and internationally. The company offers pediatric trauma and deformity correction products; scoliosis procedures for the treatment of spinal deformity; and sports medicine and other products.
Further Reading
- Five stocks we like better than OrthoPediatrics
- What Does a Stock Split Mean?
- Earn High Dividends With 2 Top REITs Set to Perform in 2025
- How to Calculate Return on Investment (ROI)
- Oilfield Leader SLB: An AI Name You Need to Know
- Stock Dividend Cuts Happen Are You Ready?
- Top ETFs That Beat the Market in 2024 and Could Do It Again
Receive News & Ratings for OrthoPediatrics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for OrthoPediatrics and related companies with MarketBeat.com's FREE daily email newsletter.